Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Brain tumor, child: Other
Trial Status:  Active
Results 1-25 of 179 for your search:
Start Over
International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: At least 3 to 5 years to under 22 years
Sponsor: Other
Protocol IDs: SIOP PNET 5 MB, 2011-004868-30, NCT02066220
An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma
Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: 22 and under
Sponsor: Other
Protocol IDs: SIOP Ependymoma II (ET-13-002), 2013-002766-39, VHP358, NCT02265770
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
Phase: Phase III
Type: Supportive care
Status: Active
Age: 1 to 21
Sponsor: Other
Protocol IDs: 06-08-367, NCT00726934
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: ACNS0831, NCI-2011-02029, COG-ACNS0831, CDR0000668560, U10CA098543, NCT01096368
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 50 and under
Sponsor: NCI, Other
Protocol IDs: AEWS1031, NCI-2011-02611, COG-AEWS1031, CDR0000687639, U10CA098543, NCT01231906
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
Phase: Phase III
Type: Supportive care
Status: Active
Age: 4 to 18
Sponsor: NCI, Other
Protocol IDs: SCUSF 1202, Previously COG-ACCL1032, 5U10CA081920, COG-ACCL1032, ACCL1032, NCT01346267
Prospective Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children
Phase: Phase III
Type: Treatment
Status: Active
Age: 2 to 18
Sponsor: Other
Protocol IDs: CCHE-BT002, NCT01878266
Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to 25
Sponsor: NCI, Other
Protocol IDs: 2013-062, NCI-2013-02001, P30CA022453, NCT01987596
Placebo Controlled Double Blind Crossover Trial of Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma
Phase: Phase III
Type: Supportive care
Status: Active
Age: 5 to 17
Sponsor: Other
Protocol IDs: 1000039383, NCT02040376
Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: ADVL0912, COG-ADVL0912, CDR0000647587, NCT00939770
Melphalan, Carboplatin, and Sodium Thiosulfate for Patients With Central Nervous System (CNS) Embryonal or Germ Cell Tumors
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 1 to 30
Sponsor: Other
Protocol IDs: OHSU-5056, SOL-08131-L, NCT00983398
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 12 to 21
Sponsor: NCI
Protocol IDs: NCI-2012-03173, CDR667932, PBTC-029B, PBTC-029, U01CA081457, UM1CA081457, NCT01089101
New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma
Phase: Phase II, Phase I
Type: Treatment
Status: Approved-not yet active
Age: 3 to 75
Sponsor: Other
Protocol IDs: NDV-HUJ-HMO-CTIL, NCT01174537
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 4 to 21
Sponsor: Other
Protocol IDs: 10-096, NCT01294670
Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: Re-MATCH, W81XWH-10-1-0089, CDMRP-PRO93877, NCT01326104
Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2012-00082, 12-C-0213, CDR0000717423, P12978, PBTC-033, U01CA081457, NCT01514201
Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT)
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 17 and under
Sponsor: Other
Protocol IDs: 2011-0804, NCI-2011-03725, NCT01469247
Aerosol IL-2 for Pulmonary Metastases
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 12 and over
Sponsor: Other
Protocol IDs: 2010-0700, NCI-2012-00788, NCT01590069
Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 3 and over
Sponsor: Other
Protocol IDs: 2011-0844, NCI-2012-00849, NCT01596127
Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 2 to 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: TED12689, U1111-1128-5704, NCT01751308
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: CCMC1411, NCT01837862
Phase I/II Trial Of Super-Selective Intraarterial Infusion Of Erbitux and Bevacizumab For Treatment Of Relapsed/Refractory Intracranial Glioma In Patients Under 22 Years Of Age
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Under 22
Sponsor: Other
Protocol IDs: 1202012214, NCT01884740
Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma and Relapsed Glioblastoma Multiforme
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 3 to 90
Sponsor: Other
Protocol IDs: antiPD1brainad, NCT01952769
Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 5 and under
Sponsor: Other
Protocol IDs: 2012-004842-14, 2012/1908, NCT02025881
The Use of 5-aminolevulinic Acid (ALA) as an Intraoperative Tumor Marker for Resection of Pediatric Central Nervous System (CNS) Tumors
Phase: Phase II, Phase I
Type: Diagnostic
Status: Approved-not yet active
Age: 3 to 18
Sponsor: Other
Protocol IDs: TASMC-13-JR-528-CTIL, NCT02050243
Start Over